{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:51:34Z","timestamp":1793026294258,"version":"4.5.0"},"reference-count":28,"publisher":"Japanese Society of Toxicologic Pathology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Toxicol Pathol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1293\/tox.2019-0017","type":"journal-article","created":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T18:03:13Z","timestamp":1562436193000},"page":"245-251","source":"Crossref","is-referenced-by-count":34,"title":["Overexpression of interleukin-20 receptor subunit beta (IL20RB) correlates with cell proliferation, invasion and migration enhancement and poor prognosis in papillary renal cell carcinoma"],"prefix":"10.1293","volume":"32","author":[{"given":"Xi-Feng","family":"Cui","sequence":"first","affiliation":[{"name":"Department of Nephrology, The Laiyang Central Hospital of Yantai, 111 Changshan Road, Laiyang, Shandong, 265200, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Gang","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, The Yantai Affiliated Hospital of Binzhou Medical University, 717 Jinbu Road, Yantai, Shandong 264200, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Leng","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Laiyang Central Hospital of Yantai, 111 Changshan Road, Laiyang, Shandong, 265200, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"121","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ng CS, Wood CG, Silverman PM, Tannir NM, Tamboli P, and Sandler CM. Renal cell carcinoma: diagnosis, staging, and surveillance. AJR Am J Roentgenol. 191: 1220\u20131232. 2008.","DOI":"10.2214\/AJR.07.3568"},{"key":"2","unstructured":"2. Liu K, Ren Y, Pang L, Qi Y, Jia W, Tao L, Hu Z, Zhao J, Zhang H, Li L, Yue H, Han J, Liang W, Hu J, Zou H, Yuan X, and Li F. Papillary renal cell carcinoma: a clinicopathological and whole-genome exon sequencing study. Int J Clin Exp Pathol. 8: 8311\u20138335. 2015."},{"key":"3","unstructured":"3. Koul H, Huh JS, Rove KO, Crompton L, Koul S, Meacham RB, and Kim FJ. Molecular aspects of renal cell carcinoma: a review. Am J Cancer Res. 1: 240\u2013254. 2011."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Chen J, Caspi RR, and Chong WP. IL-20 receptor cytokines in autoimmune diseases. J Leukoc Biol. 104: 953\u2013959. 2018.","DOI":"10.1002\/JLB.MR1117-471R"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Wirtz MK, and Keller KE. The role of the IL-20 subfamily in glaucoma. Mediators Inflamm. 2016: 4083735. 2016.","DOI":"10.1155\/2016\/4083735"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Reimann E, Kingo K, Karelson M, Reemann P, Loite U, Sulakatko H, Keermann M, Raud K, Abram K, Vasar E, Silm H, and K\u00f5ks S. The mRNA expression profile of cytokines connected to the regulation of melanocyte functioning in vitiligo skin biopsy samples and peripheral blood mononuclear cells. Hum Immunol. 73: 393\u2013398. 2012.","DOI":"10.1016\/j.humimm.2012.01.011"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kingo K, M\u00f6ssner R, R\u00e4tsep R, Raud K, Kr\u00fcger U, Silm H, Vasar E, Reich K, and K\u00f5ks S. Association analysis of IL20RA and IL20RB genes in psoriasis. Genes Immun. 9: 445\u2013451. 2008.","DOI":"10.1038\/gene.2008.36"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Baird AM, Gray SG, and O\u2019Byrne KJ. IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF. Eur J Cancer. 47: 1908\u20131918. 2011.","DOI":"10.1016\/j.ejca.2011.04.012"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gao F, Zhao ZL, Zhao WT, Fan QR, Wang SC, Li J, Zhang YQ, Shi JW, Lin XL, Yang S, Xie RY, Liu W, Zhang TT, Sun YL, Xu K, Yao KT, and Xiao D. miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells. Biochem Biophys Res Commun. 431: 610\u2013616. 2013.","DOI":"10.1016\/j.bbrc.2012.12.097"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Omarini C, Bettelli S, Caprera C, Manfredini S, Caggia F, Guaitoli G, Moscetti L, Toss A, Cortesi L, Kaleci S, Maiorana A, Cascinu S, Conte PF, and Piacentini F. Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients. Cancer Biol Ther. 19: 879\u2013886. 2018.","DOI":"10.1080\/15384047.2018.1480287"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Haider S, Wang J, Nagano A, Desai A, Arumugam P, Dumartin L, Fitzgibbon J, Hagemann T, Marshall JF, Kocher HM, Crnogorac-Jurcevic T, Scarpa A, Lemoine NR, and Chelala C. A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma. Genome Med. 6: 105. 2014.","DOI":"10.1186\/s13073-014-0105-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lamouille S, Xu J, and Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 15: 178\u2013196. 2014.","DOI":"10.1038\/nrm3758"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kalluri R, and Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 119: 1420\u20131428. 2009.","DOI":"10.1172\/JCI39104"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Siegel RL, Miller KD, and Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 65: 5\u201329. 2015.","DOI":"10.3322\/caac.21254"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Low G, Huang G, Fu W, Moloo Z, and Girgis S. Review of renal cell carcinoma and its common subtypes in radiology. World J Radiol. 8: 484\u2013500. 2016.","DOI":"10.4329\/wjr.v8.i5.484"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Choueiri TK, Plimack E, Arkenau HT, Jonasch E, Heng DYC, Powles T, Frigault MM, Clark EA, Handzel AA, Gardner H, Morgan S, Albiges L, and Pal SK. Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer. J Clin Oncol. 35: 2993\u20133001. 2017.","DOI":"10.1200\/JCO.2017.72.2967"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rutz S, Wang X, and Ouyang W. The IL-20 subfamily of cytokines--from host defence to tissue homeostasis. Nat Rev Immunol. 14: 783\u2013795. 2014.","DOI":"10.1038\/nri3766"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Gallagher G, Dickensheets H, Eskdale J, Izotova LS, Mirochnitchenko OV, Peat JD, Vazquez N, Pestka S, Donnelly RP, and Kotenko SV. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun. 1: 442\u2013450. 2000.","DOI":"10.1038\/sj.gene.6363714"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Blumberg H, Conklin D, Xu WF, Grossmann A, Brender T, Carollo S, Eagan M, Foster D, Haldeman BA, Hammond A, Haugen H, Jelinek L, Kelly JD, Madden K, Maurer MF, Parrish-Novak J, Prunkard D, Sexson S, Sprecher C, Waggie K, West J, Whitmore TE, Yao L, Kuechle MK, Dale BA, and Chandrasekher YA. Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell. 104: 9\u201319. 2001.","DOI":"10.1016\/S0092-8674(01)00187-8"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Lebedeva IV, Su ZZ, Chang Y, Kitada S, Reed JC, and Fisher PB. The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells. Oncogene. 21: 708\u2013718. 2002.","DOI":"10.1038\/sj.onc.1205116"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Parrish-Novak J, Xu W, Brender T, Yao L, Jones C, West J, Brandt C, Jelinek L, Madden K, McKernan PA, Foster DC, Jaspers S, and Chandrasekher YA. Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J Biol Chem. 277: 47517\u201347523. 2002.","DOI":"10.1074\/jbc.M205114200"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Santamaria PG, Moreno-Bueno G, Portillo F, and Cano A. EMT: Present and future in clinical oncology. Mol Oncol. 11: 718\u2013738. 2017.","DOI":"10.1002\/1878-0261.12091"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Rasti A, Madjd Z, Abolhasani M, Mehrazma M, Janani L, Saeednejad Zanjani L, and Asgari M. Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma. Clin Exp Med. 18: 177\u2013190. 2018.","DOI":"10.1007\/s10238-017-0481-2"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Pasquier J, Abu-Kaoud N, Al Thani H, and Rafii A. Epithelial to mesenchymal transition in a clinical perspective. J Oncol. 2015: 792182. 2015.","DOI":"10.1155\/2015\/792182"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J, and Nieto MA. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene. 21: 3241\u20133246. 2002.","DOI":"10.1038\/sj.onc.1205416"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Miyoshi A, Kitajima Y, Kido S, Shimonishi T, Matsuyama S, Kitahara K, and Miyazaki K. Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma. Br J Cancer. 92: 252\u2013258. 2005.","DOI":"10.1038\/sj.bjc.6602266"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Imai T, Horiuchi A, Wang C, Oka K, Ohira S, Nikaido T, and Konishi I. Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol. 163: 1437\u20131447. 2003.","DOI":"10.1016\/S0002-9440(10)63501-8"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Satelli A, and Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 68: 3033\u20133046. 2011.","DOI":"10.1007\/s00018-011-0735-1"}],"container-title":["Journal of Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tox\/32\/4\/32_2019-0017\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T23:46:20Z","timestamp":1572047180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tox\/32\/4\/32_2019-0017\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1293\/tox.2019-0017","relation":{},"ISSN":["0914-9198","1881-915X"],"issn-type":[{"value":"0914-9198","type":"print"},{"value":"1881-915X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}